Identification of genes involved in trophoblast differentiation is of great interest in understanding cellular and molecular mechanisms involved in placental development and is relevant clinically to fetal development, fertility, and maternal health. Herein, we investigated differentiation of human embryonic stem cells (hESCs) down the trophoblast lineage by culture with bone morphogenetic protein 4 (BMP4) over a 10-day period. Within 2 days, the stemness markers POU5F1 and NANOG were markedly down-regulated, followed temporally by up-regulation of the CDX2, KRT7, HLA-G, ID2, CGA, and CGB trophoblast markers. To understand, on a global scale, changes in the transcriptome during the differentiation of hESCs down the trophoblast lineage, a large-scale microarray analysis was performed. Through whole-genome analysis, more than 3800 genes displayed statistically significant and 2-fold or greater changes in expression during the time course. Of those genes that showed the largest increases, many were involved in processes associated with trophoblast biology; however, novel genes were also identified. Some of them are hypothesized to be associated mainly with extracellular matrix remodeling (e.g., NID2) and cell migration and invasion (e.g., RAB25). Using Ingenuity pathways analysis software to identify signaling pathways involved in trophoblast differentiation or function, we discovered that many genes are involved in WNT/beta-catenin, ERK/MAPK, NFKB, and calcium signaling pathways, suggesting potential roles for these families in trophoblast development. This work provides an in vitro functional genomic model with which to identify genes involved in trophoblast development.
INTRODUCTION
The trophoblast is an extraembryonic tissue essential for development in mammals. The morphological precursor to different trophoblast phenotypes is present in the blastocyst stage embryo as an outer epithelial layer, the trophectoderm, surrounding the blastocoele cavity and the pluripotent inner cell mass (ICM). The trophectoderm initiates embryonic implantation through attachment of the conceptus to the receptive maternal endometrium. In humans, cells of the trophectoderm differentiate down several trophoblast lineages and fuse to form a syncytium with multinucleated syncytiotrophoblasts that produce human chorionic gonadotropin (HCG) [1] . Subsequently, the trophoblast expands and gives rise to different cell types, mainly villous cytotrophoblasts and extravillous cytotrophoblasts, to support embryonic patterning and fetal growth and nutrition [2] . Abnormalities in any of these processes result in infertility, miscarriage, intrauterine fetal growth restriction, and pre-eclampsia [3] . Investigation of the molecular regulation of trophectoderm/trophoblast early developmental stages is anticipated to yield important knowledge relevant to human infertility and maternal and fetal health.
The mouse model has been extensively used to follow trophoblast development from the blastocyst stage to the functional placenta [4] . Regarding early developmental stages, recent studies suggest that the genesis of the trophectoderm is dependent on two mechanisms: asymmetric divisions within the morula that allocate cells to the outer position and allow their polarization in opposition to apolarized inner cells [5] [6] ; and the activity of key transcription factors, such as Cdx2 [7] , Eomes [8] , and TeaD4 [9] [10] . In mouse, segregation of the trophectoderm and the ICM within the embryo can be achieved by reciprocal inhibition of the Pou5f1 (previously known as OCT-4) and Cdx2 genes [7] . The Esrrb [11] , Ets2 [12] , and Elf5 [13] transcription factors have been shown to be essential for subsequent maintenance of trophoblast identity. In embryos deficient in expression of one of these genes, the extraembryonic ectoderm that contains the trophoblast stem (TS) cells cannot be maintained and regresses. Finally, different growth factors such as Fgf4 and Nodal belonging to the FGF and transforming growth factor b (TGFB) signaling pathways, respectively, are necessary for proliferation of mouse TS cells [14] . In the absence of growth factors, TS cells express differentiation genes such as Ascl2 (previously known as Mash2), a marker of spongiotrophoblasts, one of the mouse trophoblast derivatives [15] . These studies give new insights into trophoblast specification and differentiation. However, there are significant differences between murine and human development that limit the usefulness of the mouse model [16] . There is scant information about the regulation of trophectoderm/trophoblast commitment in vivo in humans because of ethical considerations associated with experimental use of human embryos.
Until recently the best in vitro models for studying human trophoblast development have been choriocarcinoma-derived trophoblast cell lines (JAR or JEG3) [17, 18] and primary trophoblast cultures derived from placenta either at term or during the first trimester of pregnancy. However, these models are already committed to the trophoblast lineage, so that early lineage decisions cannot be addressed.
Fortunately, derivation of human embryonic stem cells (hESCs) from the blastocyst-ICM has provided a novel alternative with which to investigate molecular mechanisms that regulate the first stages of trophoblast development in humans. Indeed, hCG secretion has been reported with hESC line derivation as a consequence of their spontaneous differentiation during maintenance in culture [19] . Moreover, it has been shown that trophoblast differentiation can be induced by BMP4 treatment of hESC lines (H1, H7, H9, or H14) [20] [21] [22] or in a three-dimensional (3D) model of differentiation by the embryoid body [23] [24] [25] . These previous studies examined morphologic and molecular changes occurring during trophoblast differentiation of hESCs. Herein, we have expanded upon these studies of the H7 hESC line treated with BMP4 and have analyzed global gene expression changes over a time course. Our microarray analyses revealed that more than 3800 genes are down-or up-regulated during trophoblast differentiation. Furthermore, we have identified major biological pathways involved in this process by using gene ontology databases. Finally, we describe the signaling pathways that play a role in trophoblast differentiation and/or function. This study provides new information about the genetic regulation of the early stages of trophoblast differentiation in humans and has identified new genes not previously described during the development of this extraembryonic tissue.
MATERIALS AND METHODS
hESC Maintenance and Differentiation hESCs (the federally registered cell line H7 obtained from WiCell Research Institute) were routinely maintained on irradiated mouse embryonic fibroblast (MEF) feeders in knockout serum replacer medium consisting of 80% KnockOut Dulbecco modified Eagle medium (Invitrogen, Carlsbad, CA), 20% KnockOut serum replacement (Invitrogen), 2 mM L-glutamine (Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 0.1 mM 2-mercaptoethanol (2-ME, Sigma), 100 U/ml penicillin (Invitrogen), 100 lg/ml streptomycin (Invitrogen), and 4 ng/ml recombinant human basic fibroblast factor (rhbFGF, Invitrogen). Cell colonies were passaged using 1mg/ml type IV collagenase (Invitrogen) at a 1:3 ratio every 5 to 7 days.
For trophoblast differentiation, hESCs were first maintained for one passage under feeder-free conditions by being manually passaged on plates coated with Matrigel (BD Biosciences) and cultured in MEF-conditioned medium supplemented with rhbFGF. Feeder-free hESC cultures were treated with Accutase (Innovative Cell Technologies) at 378C for 1-2 min to dissociate colonies into single cells. The cells were collected by centrifugation, counted, and replated at 1 3 10 5 cells per well in 12-well plates (2.5 3 10 4 cells/cm 2 ) and allowed to recover in MEF-conditioned medium supplemented with rhbFGF. Trophoblast differentiation was induced 24 h later (Day 0 [D0]) by withdrawing rhbFGF and adding recombinant human BMP4 (100 ng/ml). The cells were maintained in culture for 12 days, and the medium was changed every day. For analysis of differentiation, a time course was performed during the culture period: Days 0, 2, 4, 6, 8, and 10. Day 0 refers to the time point just before initiation of differentiation by BMP4. Each time point corresponds to a pool of 3 wells of 12-well plates. The time course was performed in three independent experiments. At each time point, cells were observed with phase-contrast microscopy and collected for real-time quantitative reverse transcriptase-PCR (qRT-PCR) or fixed for immunocytochemistry. Supernatants were collected to measure hCG secretion. As a negative control, hESCs were differentiated under spontaneous conditions in the absence of MEF-secreted factors and bFGF (hereafter called noninduced differentiated cells).
Total RNA Isolation and Microarray Hybridization
Total RNA was extracted from cells by using the TRIzol method according to the protocol recommended by the manufacturer (Life Technologies, Inc.). The purified total RNA was stored at À808C until cells from all time points were collected. RNA was quantified by spectrophotometry, and its quality was assessed using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). Only samples with an RNA integrity number of .8.0 were used for microarray analysis. Hybridization was performed using Affymetrix Human Gene version 1.0 ST arrays (Affymetrix, Santa Clara, CA). Briefly, for each sample, 100 ng of total RNA was retrotranscripted to cDNA by using 500 ng of T7-(N6) primers and SuperScript II. A second strand of DNA was generated by using the DNA polymerase enzyme, followed by an overnight in vitro transcription to generate cRNA. After samples were processed using cRNA cleanup spin columns, 10 lg of cRNA was retrotranscripted using random primers and SuperScript II. Mixtures were digested with RNase H, and the cDNA was purified using cDNA cleanup spin columns. Finally, 5.5 lg of sense cDNA was fragmented and labeled using the GeneChip WT terminal labeling kit (Affymetrix). The quality of cDNA and fragmented cDNA was assessed by the Agilent Bioanalyzer. Microarrays were hybridized, washed, stained, and scanned according to the protocol described in the WT sense target labeling assay manual (version 4; product number FS450_0007).
Statistical and Bioinformatic Analysis
Bioinformatic statistical analysis was performed using Bioconductor functions (http://www.bioconductor.org/) in R software (http://www.r-project. org/). To remove all possible sources of variation of nonbiological origin between arrays, data were normalized using the RMA normalization function implemented in the Bioconductor affylmGUI package (http://www. bioconductor.org/packages/2.0/bioc/html/affylmGUI.html). Then, we selected those probes with known gene symbol identities, and the values corresponding to redundant symbols were averaged. Statistically significant differences between groups were identified using the nonparametric test implemented in the RankProd software (http://www.bioconductor.org/packages/2.2/bioc/html/ RankProd.html). Functional annotations were carried out using Ingenuity (http://www.ingenuity.com/) software, where gene symbols and fold change of the up-and down-regulated genes were imported.
Gene Ontology Classification
Gene ontology functional annotations were carried out using Ingenuity software, with a P value of 0.05 as the classification criteria.
Real-Time RT-PCR
Samples of the total RNA that had been isolated for the microarray analysis were used to generate cDNA. Reverse transcription was performed with 0.5 lg of total RNA, using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). Real-time PCR was performed in duplicate using the Brilliant SYBR Green PCR kit (Stratagene, La Jolla, CA). The PCR amplification reaction mixture consisted in 12.5 ll of Brilliant SYBR Green Master Mix, 5 ll of 1.5 lM forward and reverse primers, and 6.5 ll of distilled water in a total volume of 25 ll. Primer sequences are shown in Supplemental Table S1 (available online at www.biolreprod.org). The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping gene was chosen as the normalizer. Primer performance and quality were assessed by standard curves with serial dilutions of pooled samples. The efficiencies of amplification for each gene were obtained using Mx3005P software (Stratagene) in the exponential phase of the amplification curve. PCR thermal profiles were run using the Mx3005 software, and CT values were calculated by the Mx3005P software.
Immunofluorescence Analysis
hESC were induced to differentiate in 24-well plates on Matrigel-coated plastic coverslips washed with PBS, fixed in 4% paraformaldehyde for 20 min at room temperature, washed three times in PBS, permeabilized in cold methanol for 5 min, and washed three times in PBS. Coverslips were stored at 48C until cells from all time points were collected. Nonspecific reactivity was blocked for 1 h by incubation in 10% goat serum. Then, cells were incubated for 1 h at room temperature or overnight at 48C with mouse anti-CDX2 (Biogenex Laboratories Inc., San Ramon, CA) diluted 1:200 and rat anticytokeratin (7D3) diluted 1:50. Species-specific fluorescein-or rhodamine-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) were used according to the manufacturer's recommendations (dilution, 1:1000). Cells were observed with a Leica DM 500B fluorescence microscope (Leica Microsystems, Wetzlar, GDR).
Immunoassays of Human Chorionic Gonadotropin
The conditioned medium from differentiating hESC was collected every 2 days from D0 to D12. The HCG concentration was analyzed using an HCG ELISA kit (Bioquant, San Diego, CA).
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RESULTS
Trophoblast Differentiation of Cultured hESCs
Two different strategies have been used previously to differentiate trophoblast from hESC lines: the BMP4 model that consists of 2D adherent cultures treated with BMP4, a member of the TGFB superfamily [20] [21] [22] , and the embryoid body (EBs) model, corresponding to 3D cultures [23] [24] [25] . Here we performed a series of experiments based on BMP4 treatment (100 ng/ml) of H7 and H9 cell lines for up to 12 days. Unique to the current study is that the differentiation experiments were performed with a starting material of a single hESC population rather than hESC colonies in order to understand the effects of BMP4 on differentiation of a homogeneous population. To establish the timing in which trophoblast differentiation and trophectoderm/trophoblast transitions occur, a time course experiment consisting of seven points was designed (Days 0, 2, 4, 6, 8, 10, and 12).
With BMP4 treatment, typical morphological changes were observed with H7 (Fig. 1A ) or H9 cells (data not shown), as described previously [22] . Flattened cells with enlarged prominent nuclei began to appear on D2 and became more evident at D4 and D6 of differentiation ( Fig.  1A ) than noninduced differentiated cells that resulted in a mixed population of fibroblastic and neural cells. Moreover, morphological changes were less homogenous when hESCs were differentiated as colonies (data not shown), suggesting that the use of a homogenous (single-cell) population as the starting material avoids delayed differentiation and preservation of larger areas of undifferentiated cells. The homogenous morphological changes observed in the BMP4-treated single-cell population coincided with secretion of hCG and its increase between D6 and D12 (Fig. 1B) . To confirm that these culture conditions produced a trophoblast cell population, we performed qRT-PCR assay for a number of markers of pluripotency and trophoblast development at various stages throughout differentiation (Fig. 1, C and D) . NANOG expression decreased immediately after the differentiation was induced or not by BMP4, showing the rapid onset of differentiation of hESCs. POU5F1 and SOX2 expression (data not shown) also decreased during the time course. Cdx2 and Krt7 (previously known as cytokeratin 7) expression, markers of mouse trophectoderm and epithelial cells, respectively, showed a rapid and transient increase at D4 in the protocol using BMP4. Minimal expression was observed in noninduced differentiation of hESCs, suggesting that BMP4-treated cells underwent a commitment to the trophoblast lineage. Immunostaining revealed colocalization of CDX2 and KRT7 within differentiated cells, reinforcing the hypothesis that hESCs could specify into trophectoderm/ trophoblast-like progenitors with BMP4 treatment (Supplemental Fig. S1 ). The ID2 and HLA-G trophoblast-specific genes were also induced between D0 and D4 of differentiation, and their expression levels persisted throughout the differentiation process. Finally, the CGA and CGB expression levels were highly induced at a later stage of differentiation (D12) in BMP4-treated cells. Figure 1D illustrates the transitions in gene expression observed in these experiments. The sequence of gene expression changes observed suggests the emergence of trophectoderm/trophoblast-like progenitors was followed by trophoblast differentiation. Comparison with noninduced differentiation of hESCs demonstrated the robustness of the BMP4 protocol for studying early events of trophoblast differentiation in this in vitro model.
Functional Genomics of BMP4-Treated hESC Differentiation
To examine changes in gene expression during differentiation of hESCs down the trophoblast lineage, RNA was isolated from H7 cells treated with BMP4 at seven different time points from D0 to D10. The transcriptional analysis was performed using Affymetrix human gene 1.0 ST arrays containing 28 132 probe sets.
Principal component analysis (PCA) is a statistical method that allows projecting higher-dimension data onto a lowerdimension space. When PCA is applied to data, samples with similar trends in their gene expression profiles tend to cluster together. Figure 2A shows clusters corresponding to the process of hESC differentiation from D0 to D10. Differences in the gene expression profiles increased as the experiment progressed (from D0 to D10) ( Fig. 2A) . Temporal analysis was conducted, with the first day as a reference point, and then each subsequent day was compared to this reference time. This method provided information for the number of genes up-and down-regulated during the differentiation process. Figure 2B shows the number of up-and down-regulated genes at each time point compared with those at D0. The number of genes up-and down-regulated between one time point and the previous time point increased progressively with BMP4 treatment (Fig. 2C) , underscoring the fact that the gene expression profile changes temporally according to progression of the differentiation process.
Examination of Gene Regulation During Trophoblast Differentiation
To gain an understanding of the biological processes occurring during differentiation of hESCs, we performed gene clustering. K-means clustering was used to categorize the genes into groups with similar temporal changes. Three clusters were generated, as it was found this number gave the best representation of the different major kinetic trends in this experiment. The first cluster contained genes that are rapidly down-regulated during differentiation of hESCs (Fig. 3A , Table 1 , and Supplemental Table S2 ). The second cluster included genes that were gradually increased upon differentiation of hESCs, with the highest expression at D10 (Fig. 3B , Table 2, and Supplemental Table S3 ), whereas in cluster three, genes displayed a transient up-regulation around D4 and D6 of differentiation (Fig. 3C, Table 3 ).
hESC-Enriched Genes
It was expected that genes necessary for maintenance and self-renewal of hESCs would be rapidly down-regulated during differentiation. We identified genes that displayed rapid downregulation that included well-established key pluripotencycontrolling genes such as NANOG, POU5F1, and SOX2 [27] , and their downstream target, ZIC3 (Fig. 3A, Table 1 ) [28] . A larger cluster of 449 gene entries with similar expression patterns is shown in Supplemental Table S2 . As anticipated, components of signal transduction pathways implicated in the maintenance of pluripotency, such as activin/nodal/ TGFB (coreceptor TDGF1 and downstream targets LEFTY2 and CER1), FGF (FGF2), and notch (NOTCH1) were down-regulated upon hESC differentiation. The de novo methyltransferase DNMT3B gene involved in the epigenetic control of pluripotency was also down-regulated, as was CDC25A, required for progression from G1 to the S-phase of the cell cycle, and consistent with the limited G1 phase and rapid cell cycle characteristic of undifferentiated ESC [29] . The results demonstrated that the approach used could identify genes that may be involved in the control of hESC self-renewal. To verify the microarray results, expression levels of known genes were examined by qRT-PCR in three independent experiments (Fig. 4) . The observation of rapid down-regulation of CER1 and SOX2 expression confirmed the microarray results.
Cell Lineage Markers
It has previously been shown that short-term BMP4 treatment initiates mesoderm induction at a high efficiency in hESCs [30] . This has been suggested by detection of high brachyury expression at D1 of differentiation, which decreased dramatically at D2. As expected, no up-regulation of brachyury expression, as well as other established markers of mesendoderm such as Wnt3, Mixl1, and Gsc, was detected in our 1262 experiments with long-term BMP4 treatment. Moreover, the early extraembryonic endoderm marker Gata6 and the late extraembryonic markers Sox7 and Afp were not up-regulated upon differentiation of hESCs. Finally, we detected no upregulation of the endoderm-associated Sox17, Cxcr4, and Foxa2 genes and the ectoderm-associated Sox1, Pax6, nestin (Nes), and Zic1 genes. These results showed that little or no endoderm, mesoderm, ectoderm, and extraembryonic endoderm differentiation occurred under the conditions of long-term BMP4 treatment, confirming that hESC differentiation under these culture conditions is a robust model for studying trophoblast differentiation. 
Trophoblast-Enriched Genes
The genes responsible for trophoblast differentiation and function are expected to be up-regulated during hESC differentiation. We identified a cluster of genes with expression up-regulated from D0 to D10 (Fig. 3B, Table 2 , and Supplemental Table S3 ). Several genes in the list have previously been shown to be involved in trophoblast development, such as the well-established CGA and CGB markers and the GCM1 marker, which is required for syncytiotrophoblast development and the proper branching of trophoblast villi [31] . Others included the ID2 gene, which regulates critical aspects of human cytotrophoblast differentiation, invasion, and migration [32] ; the GATA2 and GATA3 genes, which are important in vivo regulators of trophoblastspecific gene expression and placental function [33] ; the LIF receptor (LIFR) gene, which is expressed by the trophoblast and required for activation of the STAT3 signaling pathway and subsequent invasion of trophoblast within the endometrium [34] ; and the HSD3B1 gene, which is required for biosynthesis of placental progesterone and, thus, is essential for pregnancy maintenance [35] . Others included the placental-specific IGF2 gene, a major modulator of placental and fetal growth [36] , and the MUC15 and HGF genes, which play a critical role in regulating trophoblast invasion [37, 38] . We also detected upregulation of cytoskeletal and extracellular matrix-associated genes, such as MFAP5, TIMP2, COL4A1, LOXL4, KRT7, and KRT8, crucial for trophoblast differentiation and invasion within the maternal endometrium. Finally, we identified new genes, such as EPAS1 (previously known as HIF2alpha), which may represent an important regulator of vascularization, perhaps involving the regulation of endothelial cell gene expression in response to hypoxia [39] , and the COL3A1, COL6A3, and NID2 genes, which are extracellular matrixassociated genes. A larger cluster of 670 gene entries is shown in Supplemental Table S3 . Moreover, real-time RT-PCR analysis of CGA and CGB expression confirmed the upregulated gene expression profile obtained by microarrays (Fig.  4) .
Transiently Up-Regulated Genes
To identify genes involved in the commitment of hESC down the trophoblast lineage, clustering analysis of transiently regulated genes at D4 and/or D6 of differentiation was performed. These time points were chosen because they occur prior to the HCG secretion that characterizes fully differentiated cells (Fig. 1B) . Clustering analysis revealed a group of 19 genes (Fig. 3C, Table 3 ) that were transiently co-up-regulated. Interestingly, in addition to seven new genes, the clustered group contained genes shown previously to be important for trophoblast development. For example, the HAND1 gene promotes differentiation of trophoblast cells [40] . The KRT7 gene is a well-established marker of syncytiotrophoblast epithelial cells. The TFAP2A gene (previously known as AP2 alpha) plays a critical role in human trophoblast differentiation [41] . The PRLR gene is the receptor of prolactin that is secreted by the decidualized endometrium at the time of blastocyst nidation and, thus, is involved in local autocrine-paracrine signaling at the decidua-placenta interface, crucial for successful establishment of pregnancy. The MSX2 gene, a homeobox transcription factor, is also expressed in the epithelial-mesenchymal cell layers of developing chorionic villi of human placentae [42] . While their roles have not yet been elucidated, the GABRP and ATP12A genes were detected in both the uterus and trophoblast in humans [43] . The HPGD gene contributes to the tight regulation of prostaglandin action in the endometrium and transiently in the trophoblast, especially at the critical period of recognition of pregnancy. The CDH1 gene (previously known as E-cadherin), highly expressed in ovine endometrium and trophectoderm, may have important roles in trophoblast differentiation, including rearrangement of cadherin-mediated cell adhesion during cell migration [44] . Finally, the secreted chemokine CXCL12 gene is essential for the global crosstalk between the trophoblast and the endometrium during the invasive phase of implantation [45] . Among the new genes not previously described as involved in trophoblast development, we indentified the GRHL2 and GRHL3 transcription factors; the RAB25 GTPase that has been previously shown to promote the ability of tumor cells to invade the extracellular matrix [46] ; the calcium release channel RYR2 gene; the protogenin (PRTG) gene, a novel immunoglobulin superfamily gene [47] ; the HAPLN1 gene (previously known as CRTL1), which is an extracellular matrix component; and the CTSL2 gene, a cysteine proteinase that could play a role in matrix degradation [48] , possibly involved in the invasion process. Real-time RT-PCR analysis of HAND1 and CTSL2 expression was performed upon differentiation of hESC (Fig. 4) , confirming the specific profile of transiently upregulated genes described above.
Identification of Signaling Pathways Potentially Involved in Trophoblast Differentiation
To identify pathways active in hESC differentiation to trophoblast, pathway analysis was performed using Ingenuity software. For this analysis, we selected the same group of genes that showed similar gene expression during the BMP4 treatment (449 up-regulated, 670 down-regulated, and 19 transiently up-regulated genes [ Fig. 3]) . We found that during the differentiation process, many signaling pathways were overrepresented. Canonical pathways and the genes involved in each one are shown in Table 4 . In the up-regulated genes, the presence of WNT/b-catenin signaling, interleukin 8 (IL8) signaling, NFjB signaling, ERK/MAPK signaling, and PDGF signaling, and the metabolism of purines and pyrimidines are notable. The group of down-regulated genes includes the IL8 and BMP signaling pathways and different pathways related to lipid metabolism. Only four canonical pathways in the list of genes that were transiently up-regulated during the period D4-D6 were determined, and these include calcium signaling, leukocyte extravasation signaling, C21-steroid hormone metabolism, and mechanisms of viral exit from host cells. Many TRANSCRIPTOMIC SIGNATURE OF TROPHOBLAST of these canonical pathways have been previously described as specific for trophoblast cells [49] .
DISCUSSION
Two major strategies have been used in the past to generate trophoblast-like cells from hESC lines: the EB model, corresponding to 3D cultures [23] [24] [25] , and the BMP4 model, which consists of 2D adherent cultures treated with BMP4, a member of the TGFB superfamily [20] [21] [22] . However, the differentiation process in the former model is less homogenous than that in the latter. In the EB model, cells of the three germ layers were present, as shown by the expression of genes characteristic of ectoderm, mesoderm, and endoderm [25] . Expression of these markers was not detected in hESC cultures treated with BMP4 for up to 7 days [20] . Moreover, morphologic and physiologic features of BMP4-treated hESC cultures have been well characterized [22] . Immunostaining showed that BMP4 treatment initiated trophoblast differentiation from the periphery of hESC colonies and that removal of FGF2 (previously known as bFGF), the crucial factor for hESC self-renewal and proliferation, accelerated this process. This differentiation patterning of hESC colonies could be due to different microenvironmental changes by the cells according to their position within the colony and the communication of information to their neighbors through chemical gradients and/ or cell-to-cell contact [22] .
In the present study, we describe the temporal gene expression profile of hESCs when they differentiate along through the extraembryonic trophoblast lineage. We first confirmed that hESCs treated with BMP4 in a 2D culture system can be used as an effective model to study trophoblast cell commitment by following morphological changes and expression of well-established cell lineage markers (Fig. 1,   Supplemental Fig. S1 ). Real-time RT-PCR analysis showed rapid down-regulation of POU5F1, SOX2, and NANOG expression, which form a trio of transcription factors controlling the balance between self-renewal and differentiation of hESCs [50] . The NANOG gene, which is specifically expressed in the ICM within the human blastocyst stage embryo but is not expressed in the surrounding trophectoderm (Fisher et al., unpublished data), showed an immediate decrease in expression (with or without BMP4 treatment), demonstrating the rapid onset of differentiation of hESCs. POU5F1 and SOX2 expression (data not shown) also decreased during the time course. However, a delay of 48 h (D2) was observed in BMP4-treated cultures. This result is consistent with the gene expression profile observed when hESCs lose their pluripotency and acquire a trophoblast phenotype after inhibition of activin/nodal signaling [51] . It is also in accordance with observations recently reviewed by Douglas et al. [52] and Roberts and Fisher [53] . First, unlike those in the mouse system and despite their role in maintaining the pluripotency state, human POU5F1 and SOX2 genes may not be suitable markers for distinguishing between ICM pluripotent stem cells and trophectoderm cells. Indeed, the POU5F1 gene is expressed in vitro by both undifferentiated hESCs and early differentiated cells, and its expression is lost as differentiation occurs. Within the human blastocyst, POU5F1 expression localized in both the ICM and the trophectoderm layers (Fisher et al., unpublished data) . Similarly, the SOX2 gene is also highly expressed in TS cells [54] . Both of them may be factors potentiating stemness of both hESCs and TSCs [53] .
Our differentiation assay showed up-regulation of trophoblast markers (KRT7, CDX2, ID2, HLA-G, CGA, and CGB) upon differentiation of hESC treated with BMP4 in comparison with expression of noninduced, differentiated cells. Immuno- 1266 staining analysis also demonstrated that differentiated hESC acquired an epithelial phenotype typical of trophectoderm, suggested by colocalization of KRT7 and CDX2. Finally, differentiated cells behaved as syncytiotrophoblast cells by secreting HCG. These results suggest that hESCs adopted a differentiated fate down the trophoblast lineage. In order to define the transcriptome of the early trophoblast cell lineage decision, we performed a temporal microarray gene expression profile during induced differentiation of hESCs into trophoblast cells. By comparing differentiated cells from Days 2, 4, 6, 8, and 10 of differentiation to undifferentiated hESCs (D0), we generated a dataset represented by more than 3800 genes that were differentially expressed over time. We identified a large number of genes that displayed significant increases during differentiation, many with established functions in important processes of trophoblast biology. Transcription factors such as GATA2, GATA3, HAND1, GCM1, ID2, TFAP2A, and MSX2 have a well-documented association with trophoblast differentiation. Genes involved in the invasion of trophoblasts within the maternal endometrium, like MUC15, HGF, IGF2, and CDH1, were highly represented in lists of genes showing 2-fold or greater increases. We also identified cytoskeletal-associated genes (KRT7, KRT8) and genes related to extracellular matrix remodeling (MFAP5, TIMP2, COL4A1, LOXL4). Finally, genes involved in hormonal processes (HSD3B1, PRLR, HPGD, CGA, CGB) were up-regulated upon differentiation of hESC into trophoblast. For each of these important processes, we described new genes never described in the trophoblast biology field. Some of them are mainly hypothesized to be associated with extracellular matrix remodeling (e.g., COL3A1, COL6A3, NID2, and HAPLN), and cell migration and invasion (e.g., CTSL2, RAB25, and LUM). We confirmed expression profiles of one of these new genes (CTSL2) by RT-PCR analysis.
A previous study used a similar microarray approach to define a gene signature of trophoblast cells isolated from hESCs [20] . In that study, trophoblast cells were isolated at different time points (3, 6, 12 , and 24 h; and 2, 3, and 7 days), and 14 genes were identified as strongly up-regulated at all time points examined. We compared the differentially expressed genes to our lists of genes. Although many similarities were found in that comparison, 6 of 14 genes were absent in our list. This observation could reflect either differences in the time points or culture conditions (singlecell population versus colonies or presence versus absence of bFGF treatment) used to induce differentiation of hESCs. Using Ingenuity software, we identified signaling pathways that were active upon differentiation of hESCs to trophoblast. As expected, the BMP signaling pathways was active in the group of down-regulated genes in response to the BMP4 treatment. The Wnt/b-catenin signaling pathway was active in the group of up-regulated genes upon differentiation of hESCs. It has been previously shown that activation of the canonical WNT pathway is operative during mouse and human preimplantation development [55] [56] [57] . The ERK/MAPK signaling pathway is also active in the group of genes upregulated, and a previous study showed that this activation improves the proliferative and invasive potential of human trophoblast cells [58] . Interestingly, for the first time, we report activation of the coagulation system and the pathway associated with the role of BRCA1 in DNA response to damage. According to the role these two pathways played in development, we hypothesize that they also play roles in extracellular matrix remodeling and in cytotrophoblast invasion during implantation within the endometrium. In the group of transiently up-regulated genes, we identified activation of calcium signaling pathway. Ca 2þ transfer across the syncytiotrophoblast of the human placenta is known to be essential for normal fetal development [59] . Finally, we observed activation of the leukocyte extravasation signaling pathway. This is in accordance with previous observations by Fisher and colleagues [60] that the human trophoblast remodels the endometrium using a combination of molecules that govern vasculogenesis or leukocyte extravasation.
Relevance of the hESC Model for Studying Trophoblast Development
Our microarray analysis clearly showed a trophoblast expression signature in differentiated hESCs. However, previous studies have revealed that BMP4 treatment induces not only trophoblast differentiation but also other lineage formation: in a monkey ESC model, BMP4 treatment induced primitive endoderm formation rather than trophoblast [61] and human ESCs, and induced pluripotent stem cells treated with BMP4 gave rise to a mixture of primitive endoderm and trophoblast cells [62, 63] . Moreover, short-term BMP4 treatment initiates mesoderm induction at a high efficiency in hESCs [30] . Therefore, we evaluated other lineage markers in our gene lists. We found that expression of well-established markers of embryonic mesoderm (brachyury, Wnt3, Mixl1, Gsc), endoderm (Foxa2, Sox17, Cxcr4) and ectoderm (Sox1, Pax6, nestin, Zic1) were not regulated upon differentiation of BMP4-treated hESCs. Similarly, expression of the primitive endoderm markers Gata6, Sox7, and Afp and the parietal endoderm marker laminin B1 showed no regulation during the time course differentiation protocol. We only detected the upregulation of the visceral endoderm marker Gata4. These results suggest that our BMP4-treated hESCs are mainly committed to the trophoblast differentiation lineage and not appreciably into endoderm, mesoderm, ectoderm, or extraembryonic endoderm differentiation lineages. The fact that our results differ from those of other studies [30, 62, 63] could be explained by the culture conditions (long-term versus shortterm BMP4 treatment and absence versus presence of bFGF treatment). The most difficult extraembryonic lineage to exclude in our analysis remains the extraembryonic mesoderm, a hypothetical source of TS cells in humans [53] , because trophoblasts and extraembryonic mesoderm express common markers. To our knowledge, only HLA-G, a specific marker of extravillous trophoblast cells, may help to identify a true trophoblast phenotype. In our differentiation assay, as well as in previous studies [20, 22] , expression of the HLA-G gene is up-regulated over hESC differentiation, even if a few cells express HLA-G at the protein level. Further analysis (e.g., flow cytometry) remains to be done to identify the exact proportion of each cell type within the population derived from BMP4-treated cells and to isolate a homogenous population of cells committed to the trophoblast lineage.
Finally, the real identity of the hESC-derived trophoblast cells remains to be determined. Previous hESC studies demonstrated that in vitro-generated trophoblast cells are mainly mononuclear extravillous trophoblast and multinuclear syncytiotrophoblast [20, 22] . Whether these cells are progenies of a putative intermediate TSC population remains unclear. In our microarray data, we identified up-regulated genes that are known to be involved in the initial paracrine communication between the trophoblast of the implanting blastocyst and the maternal endometrium (e.g., CXCL12), confirming the fact that cells may adopt an invasive trophoblast phenotype. Interestingly, while we detected, by using RT-PCR, a transient upregulation of the expression of the Cdx2 gene (Fig. 1C) that is required for the emergence of TSCs, we did not notice upregulation of other master genes implicated in their selfrenewal and multipotency (e.g., Eomes, TeaD4, Tcfap2c, Ets2, Elf5, Esrrb [53] ) ( Table 2 ). These data suggest that even if the BMP4-treated cells would become TS-like cells, they do not self-renew as a real pool of progenitors and differentiate very quickly to further trophoblast progenies. This leads to the conclusion that early stages of hESC to trophoblast transition in vitro are still to be determined, as little is known about the location, time of emergence, and phenotype of human TSC in vivo [53] . Further analysis by localizing gene expression within the human embryo and samples of early gestation human placenta should help to elucidate the identity of in vitroderived trophoblast cells. Gain-of-function and loss-of-function studies (e.g., RNA interference/gene overexpression in hESC differentiating cells and gene deletion in mouse models) will also help to determine which of these transcripts play key roles in early steps of trophoblast development.
In conclusion, our study defines transcriptomic signatures for trophoblast-derived hESC and provides insight into the genes involved in signaling pathways as well as an analysis of the cellular and molecular mechanisms underlying early trophoblast development in humans. This may in the future facilitate identifying biomarkers to be used as a diagnostic test to assess the quality of embryos in human in vitro fertilization and/or as targeted therapies to enhance endometrial receptivity to embryonic implantation in women with implantation-based infertility.
